Eszopiclone

🧮 Dose calculator

Insomnia · Regimen source: FDA Lunesta · 2.1

• • At least 7–8 h before planned awakening. Elderly/debilitated, severe hepatic impairment or strong CYP3A4 inhibitors: max 2 mg. Not with or right after a heavy meal. FDA Lunesta · 2FDA Lunesta · 2.2FDA Lunesta · 2.3FDA Lunesta · 2.5

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Lunesta · 8.1

  “Risk Summary Available pharmacovigilance data with LUNESTA use in pregnant women are insufficient to identify a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Lunesta · 8.2

  “Risk Summary There are no data on the presence of eszopiclone in either human or animal milk, the effects on the breastfed infant, or the effects on milk production.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Lunesta · 8.4

  “Safety and effectiveness of LUNESTA have not been established in pediatric patients.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Lunesta · 8.5

  “LUNESTA 2 mg exhibited significant reduction in sleep latency and improvement in sleep maintenance in the elderly population.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.